The present study not only reemphasized NHERF1 as a potential marker to evaluate the malignancy and progression in ALK-translocated non-small cell lung cancers, similar to what has been reported in other cancer types, but also further demonstrated the increased NHERF1 expression was regulated by ALK activation. This evidence concerns the gene ALK and non-small cell lung carcinoma.